Synthesis of low cost organometallic-type catalysts for their application in microbial fuel cell technology

Microbial fuel cells (MFCs) are a promising technology that generates electricity from several biodegradable substrates and wastes. The main drawback of these devices is the need of using a catalyst for the oxygen reduction reaction at the cathode, which makes the process relatively expensive. In th...

Description complète

Détails bibliographiques
Publié dans:Environmental technology. - 1993. - 40(2019), 18 vom: 02. Juli, Seite 2425-2435
Auteur principal: Zerrouki, A (Auteur)
Autres auteurs: Salar-García, M J, Ortiz-Martínez, V M, Guendouz, S, Ilikti, H, de Los Ríos, A P, Hernández-Fernández, F J, Kameche, M
Format: Article en ligne
Langue:English
Publié: 2019
Accès à la collection:Environmental technology
Sujets:Journal Article Organometallic complexes Schiff base bioenergy ionic liquids microbial fuel cells Waste Water
Description
Résumé:Microbial fuel cells (MFCs) are a promising technology that generates electricity from several biodegradable substrates and wastes. The main drawback of these devices is the need of using a catalyst for the oxygen reduction reaction at the cathode, which makes the process relatively expensive. In this work, two low cost materials are tested as catalysts in MFCs. A novel iron complex based on the ligand n-phenyledenparaethoxy aniline has been synthesized and its performance as catalyst in single chamber MFCs containing ionic liquids has been compared with a commercial inorganic material such as Raney nickel. The results show that both materials are suitable for bioenergy production and wastewater treatment in the systems. Raney nickel cathodes allow MFCs to reach a maximum power output of 160 mW.m-3 anode, while the iron complex offers lower values. Regarding the wastewater treatment capacity, MFCs working with Raney nickel-based cathodes reach higher values of chemical oxygen demand removal (76%) compared with the performance displayed by the cathodes based on Fe-complex (56%)
Description:Date Completed 09.09.2019
Date Revised 07.12.2022
published: Print-Electronic
Citation Status MEDLINE
ISSN:1479-487X
DOI:10.1080/09593330.2018.1442502